BioCentury
ARTICLE | Clinical News

Ruconest conestat alfa regulatory update

April 25, 2016 7:00 AM UTC

The European Commission approved an expanded label for Ruconest conestat alfa from Pharming to treat acute angioedema attacks to include adolescents with hereditary angioedema (HAE) due to complement...